Genes and Diseases (Sep 2018)

Anti-endothelial cell antibody rich sera from rheumatic heart disease patients induces proinflammatory phenotype and methylation alteration in endothelial cells

  • Mukul Rastogi,
  • Subendu Sarkar,
  • Ankita Makol,
  • Rana Sandip Singh,
  • Uma Nahar Saikia,
  • Dibyajyoti Banerjee,
  • Seema Chopra,
  • Anuradha Chakraborti

Journal volume & issue
Vol. 5, no. 3
pp. 275 – 289

Abstract

Read online

Rheumatic heart disease (RHD) is a major cause of cardiovascular morbidity and mortality in developing nations like India. RHD commonly affects the mitral valve which is lined by a single layer of endothelial cells (ECs). The role of ECs in mitral valve damage during RHD is not well elucidated. In here, anti-endothelial cell antibody from RHD patients has been used to stimulate the ECs (HUVECs and HMVECs). ECs proinflammatory phenotype with increased expression of TNFα, IL-6, IL-8, IFNγ, IL-1β, ICAM1, VCAM1, E-selectin, laminin B, and vimentin was documented in both ECs. The promoter hypomethylation of various key inflammatory cytokines (TNFα, IL-6, and IL-8), integrin (ICAM1) associated with leukocyte transendothelial migration, and extracellular matrix genes (vimentin, and laminin) were also observed. Further, the in-vitro data was in accordance with ex-vivo observations which correlated significantly with the etiological factors such as smoking, socioeconomic status, and housing. Thus, the study sheds light on the role of ECs in RHD which is a step forward in the elucidation of disease pathogenesis. Keywords: Anti-Endothelial cell antibodies, DNA methylation, Endothelial cells, Inflammation, Rheumatic heart disease